Currently, Carisma Therapeutics Inc’s (CARM) stock is trading at $0.25, marking a fall of -5.21% from last night’s close. At this price, the stock is -80.53% below its 52-week high of $1.27 and 74.52% above its 52-week low of $0.14. Based on the past 30-day period, the stock price is -43.75% below the high and +3.13% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, CARM’s SMA-200 is $0.3485. As well, it is important to consider CARM stock ratios such as price-to-sales, which is currently 0.96.
How does Carisma Therapeutics Inc (CARM) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 2 brokerage firms that recommend the stock as a Moderate Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.00 in simple terms.
Carisma Therapeutics Inc (NASDAQ: CARM) Ownership Details
I will give a breakdown of the key shareholders in Carisma Therapeutics Inc (CARM). Recent figures show that the company’s insiders hold 27.76% of shares. A total of 40 institutional investors hold shares in the company, making 19.81% of its stock and 27.42% of its float.
Jun 30, 2025, it was reported that the Company’s largest institutional holder is VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund holding total of 342.63 shares that make 0.82% of the company’s total number of shares and are currently priced at 84594.0.
The securities firm Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holds 133.2 shares of CARM, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.32%, and the holding percentage of shares is valued at 32888.0.
An overview of Carisma Therapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Carisma Therapeutics Inc (CARM) traded 1,152,089 shares per day, with a moving average of $0.3053 and price change of -0.1495. With the moving average of $0.2992 and a price change of -0.1405, about 10,739,151 shares changed hands on average over the past 50 days. Finally, CARM’s 100-day average volume is 14,228,482 shares, alongside a moving average of $0.3260 and a price change of +0.0617.
